Expiration date: 06/2025

Action: antiepileptic

Composition:

Levetiratsetam 250, 500 or 1000 mg

Indications:

• As monotherapy - in the treatment of partial seizures with secondary generalization like or without, in patients older than 16 years with newly diagnosed epilepsy
  
• as adjunctive therapy - in the treatment of partial seizures with secondary generalization like or without, at vzroslyhdetey and infants aged from 1 month to epilepsy, in the treatment of myoclonic seizures in adults and adolescents over 12 years